Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Chloropyridine >  5-[N-(TERT-BUTOXYCARBONYL)AMINO]-2-CHLOROPYRIDINE

5-[N-(TERT-BUTOXYCARBONYL)AMINO]-2-CHLOROPYRIDINE

Basic information Safety Supplier Related

5-[N-(TERT-BUTOXYCARBONYL)AMINO]-2-CHLOROPYRIDINE Basic information

Product Name:
5-[N-(TERT-BUTOXYCARBONYL)AMINO]-2-CHLOROPYRIDINE
Synonyms:
  • 5-[N-(tert-Butoxycarbonyl)amino]-2-chloropyridine ,98%
  • 5-[N-(TERT-BUTOXYCARBONYL)AMINO]-2-CHLOROPYRIDINE
  • 5-[N-(TERT-BUTOXYCARBONYL)AMINO]-2-CHLOR
  • tert-butyl N-(6-chloropyridin-3-yl)carbamate
  • N-(6-chloro-3-pyridinyl)carbamic acid tert-butyl ester
  • (6-chloro-pyridin-3-yl)-carbamic acid, tert-butyl ester
  • 5-tert-ButoxycarbonylaMino-2-chloropyridine
  • N-Boc-6-chloro-3-pyridinamine
CAS:
171178-45-3
MF:
C10H13ClN2O2
MW:
228.68
Product Categories:
  • API intermediates
Mol File:
171178-45-3.mol
More
Less

5-[N-(TERT-BUTOXYCARBONYL)AMINO]-2-CHLOROPYRIDINE Chemical Properties

Melting point:
127-129°C
Boiling point:
283.7±25.0 °C(Predicted)
Density 
1.245±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
12.06±0.70(Predicted)
Appearance
Light brown to light purple Solid
InChI
InChI=1S/C10H13ClN2O2/c1-10(2,3)15-9(14)13-7-4-5-8(11)12-6-7/h4-6H,1-3H3,(H,13,14)
InChIKey
IRHNQVINMHHEIO-UHFFFAOYSA-N
SMILES
C(OC(C)(C)C)(=O)NC1=CC=C(Cl)N=C1
More
Less

Safety Information

HazardClass 
IRRITANT
HS Code 
29333990
More
Less

5-[N-(TERT-BUTOXYCARBONYL)AMINO]-2-CHLOROPYRIDINE Usage And Synthesis

Synthesis

5350-93-6

24424-99-5

171178-45-3

Step a: To a solution of dichloromethane (200 mL) containing 6-chloropyridin-3-amine (30.0 g, 0.23 mol), DMAP (1 g), and Et3N (41.7 g, 0.47 mol) was slowly added Boc2O (54.5 g, 0.25 mol) at 0 °C. The reaction mixture was gradually warmed to room temperature and stirred overnight. Upon completion of the reaction, the reaction mixture was washed with saturated NaHCO3 solution. The aqueous phase was extracted with dichloromethane and the combined organic phases were washed with brine (100 mL) and dried over anhydrous Na2SO4. Concentration of the organic phase under reduced pressure afforded tert-butyl 6-chloropyridin-3-ylcarbamate (50.0 g, 94% yield), the product was used directly for the next reaction without further purification.1H NMR (300 MHz, CDCl3) δ 8.23 (d, J=2.7 Hz, 1H), 7.97 (d, J=6.9 Hz, 1H), 7.27-7.24 (m, 1H), 6.58 (m, 1H), 7.25 (m, 1H), 6.25 (m, 1H), 6.25 (m, 1H). 1H), 6.58 (s, 1H), 1.52 (s, 9H).

References

[1] Inorganic Chemistry, 2017, vol. 56, # 14, p. 8381 - 8389
[2] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 9, p. 1233 - 1236
[3] Patent: US2002/22624, 2002, A1
[4] Patent: US2009/253736, 2009, A1. Location in patent: Page/Page column 24
[5] Patent: US2007/249615, 2007, A1. Location in patent: Page/Page column 29; 31; 34

5-[N-(TERT-BUTOXYCARBONYL)AMINO]-2-CHLOROPYRIDINE Preparation Products And Raw materials

Raw materials

5-[N-(TERT-BUTOXYCARBONYL)AMINO]-2-CHLOROPYRIDINESupplier

Henan Sakesi Biotechnology Co. , Ltd Gold
Tel
13803717460
Email
yf79009@163.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Shanghai Sinch Parmaceuticals Tech. Co. Ltd.
Tel
+86-21-54098501
Email
sales@sinch.com.cn
Tetranov Biopharm
Tel
13526569071
Email
sales@leadmedpharm.com